Toxikon Corporation
Medical DevicesMassachusetts, United States51-200 Employees
Toxikon Corporation is a preclinical contract research organization that provides in vivo, analytical, and in vitro testing for medical devices, pharmaceuticals, and biotechnology products. It holds ISO/IEC 17025 accreditation and is registered with the US FDA and Japanese MHLW for drug and medical device testing, supporting regulatory compliance. Its services span biocompatibility, surgical and ocular models, extractable and leachable studies, risk assessments, microbiology validations, toxicology (including genetic toxicology and carcinogenicity), pharmacokinetics and toxicokinetics, ADME, chemical characterization, impurities analysis and synthesis, and bioanalytical work. Headquartered in Bedford, Massachusetts, the company traces its origins to 1982 and operates facilities that carry GLP and GMP registrations. The sites include approximately 80 animal rooms and extensive surgical suites, enabling efficacy studies, histology, and clinical pathology. In 2021, Labcorp completed its acquisition of Toxikon.
1-888-653-2347 
support@leadiq.com 
